Multi -Modal Biofabrication Strategies for Engineered Tissue Constructs
Publish Year: 1403
Type: Conference paper
Language: English
View: 57
This Paper With 19 Page And PDF Format Ready To Download
- Certificate
- I'm the author of the paper
Export:
Document National Code:
MECCONF08_025
Index date: 17 March 2025
Multi -Modal Biofabrication Strategies for Engineered Tissue Constructs abstract
The field of tissue engineering has made significant strides in recent years, driven by innovations in biofabrication technologies. Multi -modal biofabrication strategies, which integrate technologies such as microfluidics, bioprinting, and organoid culture, offer unprecedented opportunities for creating complex, functional tissue constructs. Microfluidics provides precise control over cellular environments, enabling the creation of dynamic fluidic conditions that replicate physiological conditions. Bioprinting allows for high -resolution, three -dimensional deposition of living cells and biomaterials, offering the ability to form multi -layered tissue structures with spatial accuracy. Organoid technology, which involves cultivating three -dimensional organ -like structures from stem cells, offers valuable insights into in vitro organ functionality. Together, these technologies enable the creation of tissues with greater complexity, cellular heterogeneity, and vascularization, making them more suitable for regenerative medicine and personalized healthcare. This paper explores the integration of microfluidics, bioprinting, and organoid technologies in the development of engineered tissue constructs. It discusses the synergies between these approaches and their applications in creating vascularized tissues, disease models, and personalized organ replacements. Additionally, the challenges associated with scaling these technologies for clinical applications, as well as the ethical and regulatory considerations, are examined. The potential of multi -modal biofabrication to revolutionize tissue engineering is vast, with implications for creating functional tissues for drug testing, disease modeling, and therapeutic applications. The continued development of these technologies promises to enable the fabrication of complex, patient -specific tissues and organs, improving the future of regenerative medicine and offering new solutions for unmet clinical needs.
Multi -Modal Biofabrication Strategies for Engineered Tissue Constructs Keywords:
Multi -Modal Biofabrication Strategies for Engineered Tissue Constructs authors
Nayereh Shariatgonabadi
Cellular and Molecular Biology
Parham Nabiee
PHD of Biomechanical medical engineering
Zahra Azad
Pharmaceutical Biotechnology